CLINICAL_TRIALS
trial_result
· 2019-06-11
Clinical Trial Update: Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease [Phase 2]
Summary
Phase 2 trial assessing efficacy, safety, and tolerability of selonsertib (GS-4997) in participants with diabetic kidney disease has completed with results post…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Diabetic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-06-11